March 28, 2025

Mango Intake Linked to Improved Insulin Sensitivity

Fasting insulin levels were significantly lower with mango intake, according to a new study.

Conexiant

March 28, 2025

FDA Declines Cardamyst Approval Request

The FDA declined to approve Milestone’s etripamil nasal spray for PSVT, citing manufacturing issues and a need for more data on impurities, but raised no safety or efficacy concerns.

Reuters

March 28, 2025

Cancer–Heart Death Link Exposed

Colorectal cancer patients face up to 45% higher cardiovascular mortality risk within two years of diagnosis, with Black patients and those under 50 experiencing the greatest danger, according to groundbreaking research presented at ACC.25.

Conexiant

March 28, 2025

T2D: Non-traditional CVD Risk Factors

Investigators identify and rank non-traditional risk factors for cardiovascular disease prediction.

Conexiant

March 28, 2025

New Dosing Option for Hemophilia A and B

The FDA approved Qfitlia (fitusiran) for hemophilia A or B prophylaxis in patients aged 12 and older, offering reduced bleeding rates with bi-monthly dosing.

Conexiant

March 28, 2025

Night Owls Lose Most Sleep to Screens

New study links nightly screen use to later bedtimes, lower sleep quality, and nearly an hour of lost rest each week

Conexiant

March 28, 2025

Novel Limonene-Lipid Formulation May Help Alleviate Xerostomia in Patients With Cancer

Researchers examined the combination of a novel lipid formulation and a natural citrus essential oil to determine whether it may relieve xerostomia among patients with cancer.

The ASCO Post

March 27, 2025

Does Religion Protect Mental Health?

Study reveals that religiousness is linked to lower depression rates among U.S. college students, with significant variations based on sexual orientation and religious affiliation.

Conexiant

March 27, 2025

FDA Examines Stimulant Use Trends

The FDA reviews rising adult prescription stimulant use, ongoing shortages, and efforts to ensure appropriate access and minimize nonmedical use.

Conexiant